Sonnet Biotherapeutics

Developer of immunotherapies for the treatment of cancer

placePrinceton, New Jersey, United States calendar_todayFounded 2011 groups12 employees language sonnetbio.com

Registered entities

Innovation

9 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 523 times.

YearFilings
20191
20222
20232
20247
20258
20261

Social engagement

Social engagement: 2.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%

Recent activity

2 Dec 2025
Partnership
Hyperliquid Strategies Inc.
25 Sep 2025
Product launch
Full Human Albumin-Binding (FHAB) construct
19 Sep 2025
Event
MedInvest Biotech & Pharma Conference
Coming soon